Nano cap Bacterin International (BONE) zooms up 46% on 52,000 shares this morning in response to the publication of OsteoSponge results.
24 of 25 arthrodesis patients showed radiographic fusion at 6 and 12 months involving 44 out of 45 total joints.
Consensus revenue estimates for 2014 and 2015 are $32.7M and $61M, respectively. 2013 sales were $33.1M.
10 mutual funds have positions, down from 11 a year earlier.